BofA analyst Geoff Meacham lowered the firm’s price target on Genfit to $4 from $5 and keeps an Underperform rating on the shares.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly